logo

Arcus Biosciences, Inc (RCUS)



Trade RCUS now with
  Date
  Headline
3/8/2019 6:58:57 AM Wedbush Is Raising Arcus Biosciences, Inc (RCUS) FY19 Estimate To -1.42 From -1.93
3/8/2019 6:58:41 AM Wedbush Is Raising Arcus Biosciences, Inc (RCUS) Q4 19 Estimate To -0.38 From -0.51
3/8/2019 6:58:29 AM Wedbush Is Increasing Arcus Biosciences, Inc (RCUS) Q3 19 Estimate To -0.36 From -0.49
3/8/2019 6:58:17 AM Wedbush Is Raising Arcus Biosciences, Inc (RCUS) Q2 19 Estimate To -0.35 From -0.47
3/8/2019 6:57:50 AM Wedbush Is Increasing Arcus Biosciences, Inc (RCUS) Q1 19 Estimate To -0.33 From -0.45
3/5/2019 4:29:05 PM Arcus Biosciences Q4 Loss/share $0.28 Vs. Loss $5.98 Year Ago
1/4/2019 8:32:23 AM Arcus Biosciences CFO And COO Jennifer Jarrett To Step Down, Effective Jan. 11
10/22/2018 8:31:56 AM Arcus Biosciences Appoints Kristen Hege To Its Board
10/8/2018 5:07:04 PM Wedbush Initiates Arcus Biosciences, Inc (RCUS) At Outperform With $22 Price Target
7/30/2018 8:07:42 AM Arcus Biosciences Receives Regulatory Approval To Initiate Its Phase 1 Trial For AB154
7/17/2018 8:02:31 AM Arcus Biosciences Announces Final Safety Results From Phase 1 Trial For AB928 In Healthy Volunteers
6/26/2018 8:37:56 AM Arcus And Infinity Pharma Announce Collaboration To Evaluate Lead Programs In Triple-Combination Studies
6/26/2018 8:33:50 AM Arcus Biosciences And Infinity Pharmaceuticals Enter Clinical Collaboration
6/12/2018 7:02:53 AM Arcus Biosciences Announces Promotion Of Jennifer Jarrett To COO
6/11/2018 7:34:10 AM Arcus Reports FDA Clearance Of INDs For AB928, AB122 And Initiation Of Phase 1/1b Program To Evaluate AB928 Combinations